Table of Content

Executive Summary

1 Market Overview
1.1 Market Definition
1.2 Precision Medicine: A Frontier in the Genesis of Patient-Centric Medicine
1.3 Precision Medicine: Remodeling the One-Size-Fits-All Theory to Individually Tailored Therapy
1.4 Initiatives and Programs
1.5 Precision Medicine: Enabling Technologies and Applications
1.5.1 Innovators
1.5.1.1 3D DNA Printing
1.5.1.1.1 Introduction
1.5.1.1.2 Role of 3D DNA Printing
1.5.1.2 RNA-Seq
1.5.1.2.1 Introduction
1.5.1.2.2 Role of RNA-Seq in Precision Medicine
1.5.1.2.3 Key Players
1.5.1.3 4D Molecular Imaging
1.5.1.3.1 Introduction
1.5.1.3.2 Role of 4D Molecular Imaging in Precision Medicine
1.5.1.3.3 Key Players
1.5.2 Early Adopters
1.5.2.1 CRISPR
1.5.2.1.1 Introduction
1.5.2.1.2 Role of CRISPR in Precision Medicine
1.5.2.1.3 Key Players
1.5.2.2 Blockchain
1.5.2.2.1 Introduction
1.5.2.2.2 Role of Blockchain in Precision Medicine
1.5.2.2.3 Key Players
1.5.2.3 Imaging Informatics
1.5.2.3.1 Introduction
1.5.2.3.2 Role of Imaging Informatics in Precision Medicine
1.5.2.3.3 Key Players
1.5.3 Early Majority
1.5.3.1 Artificial Intelligence (AI)
1.5.3.1.1 Introduction
1.5.3.1.2 Role of Artificial Intelligence in Precision Medicine
1.5.3.1.3 Key Players
1.5.3.2 Circulating Free DNA (cfDNA)
1.5.3.2.1 Introduction
1.5.3.2.2 Role of cfDNA in Precision Medicine
1.5.3.2.3 Key Players
1.5.3.3 Big Data
1.5.3.3.1 Introduction
1.5.3.3.2 Role of Big Data in Precision Medicine
1.5.3.3.3 Key Players
1.5.3.4 Next-Generation Sequencing (NGS)
1.5.3.4.1 Introduction
1.5.3.4.2 Role of NGS in Precision Medicine
1.5.3.4.3 Key Players
1.5.3.5 Health Informatics
1.5.3.5.1 Introduction
1.5.3.5.2 Role of Health Informatics in Precision Medicine
1.5.3.5.3 Key players
1.5.3.6 Bioinformatics
1.5.3.6.1 Introduction
1.5.3.6.2 Role of Bioinformatics in Precision Medicine
1.5.3.6.3 Key Players
1.5.4 Late Majority
1.5.4.1 Polymerase Chain Reactions (PCR)
1.5.4.1.1 Introduction
1.5.4.1.2 Role of PCR in Precision Medicine
1.5.4.1.3 Key players
1.5.4.2 Microarray
1.5.4.2.1 Role of Microarray in Precision Medicine
1.5.4.2.2 Key Players

2 Market: Industry Outlook
2.1 Precision Medicine Market: Ecosystem Analysis
2.2 Market Trends
2.2.1 Integrating Advanced Imaging for Enhanced Diagnostics and Treatment
2.2.2 Emergence of Biobanks as a Cornerstone of Precision Medicine
2.3 Industry Insights
2.3.1 Patent Analysis
2.3.2 Pipeline Analysis
2.3.3 Legal Requirements and Framework by the MHLW
2.4 Ecosystem Summary

3 Region
3.1 Overview
3.2 Asia-Pacific
3.2.1 Regional Overview
3.2.2 Driving Factors for Market Growth
3.2.3 Factors Challenging the Market
3.2.3.1 Asia-Pacific Precision Medicine Market (by Ecosystem)
3.2.4 Japan
3.2.4.1 Japan Precision Medicine Market (by Ecosystem
3.2.5 China
3.2.5.1 China Precision Medicine Market (by Ecosystem),
3.2.6 India
3.2.6.1 India Precision Medicine Market (by Ecosystem),
3.2.7 Australia
3.2.7.1 Australia Precision Medicine Market (by Ecosystem),
3.2.8 South Korea
3.2.8.1 South Korea. Precision Medicine Market (by Ecosystem)
3.2.9 Rest-of-APAC
3.2.9.1 Rest-of-APAC Precision Medicine Market (by Ecosystem)

4 Competitive Landscape
4.1 Competitive Landscape
4.1.1 Synergistic Activities
4.2 Company Profiles
4.2.1 Astellas Pharma Inc
4.2.1.1 Overview
4.2.1.2 Top Products
4.2.1.3 Top Competitors
4.2.1.4 Analyst View
4.2.2 Sysmex Corporation
4.2.2.1 Overview
4.2.2.2 Top Products
4.2.2.3 Top Competitors
4.2.2.4 Analyst View
4.2.3 Konica Minolta, Inc.
4.2.3.1 Overview
4.2.3.2 Top Products/Product Portfolio
4.2.3.3 Top Competitors
4.2.3.4 Analyst View

5 Research Methodology
5.1 Precision Medicine Market: Research Methodology
5.1.1 Data Sources
5.1.1.1 Primary Data Sources
5.1.1.2 Secondary Data Sources
5.1.2 Data Triangulation
5.2 Market Estimation and Forecast

List of Figures
Figure 1: Asia-Pacific Precision Medicine Market, $Billion, 2023, 2028, and 2034
Figure 2: Precision Medicine: Treatment Tailored to an Individual’s Genetic Structure
Figure 3: Precision Medicine - a Multi-Faceted Approach to Patient Care
Figure 4: Decreasing Cost ($) and Increasing Output (TB) of Genome Sequencing, 2009-2025
Figure 5: Asia-Pacific Precision Medicine Market (by Ecosystem), $Billion, 2023, 2028, and 2034
Figure 6: Precision Medicine Approach
Figure 7: Evolution of Precision Medicine Technology
Figure 8: Precision Medicine: Enabling Technologies and Applications
Figure 9: Structured Big Data Reporting Benefits
Figure 10: Generalized Process for the Microarray
Figure 11: Stakeholders in Precision Medicine
Figure 12: Number of Patents Files, 2020-2024
Figure 13: Precision Medicine by Top Patent Owner
Figure 14: Asia-Pacific Precision Medicine Market, $ Billion, 2023-2034
Figure 15: Japan Precision Medicine Market, $Billion, 2023-2034
Figure 16: China Precision Medicine Market, $Billion, 2023-2034
Figure 17: India Precision Medicine Market, $Billion, 2023-2034
Figure 18: Australia Precision Medicine Market, $Billion, 2023-2034
Figure 19: South Korea Precision Medicine Market, $Billion, 2023-2034
Figure 20: Rest-of-APAC Precision Medicine Market, $Billion, 2023-2034
Figure 21: Synergistic Activities, by Company (January 2020- January 2025)
Figure 22: Synergistic Activities, by Type (January 2020- January 2025)
Figure 23: Data Triangulation
Figure 24: Top-Down and Bottom-Up Approach

List of Tables
Table 1: Market Snapshot
Table 2: Application
Table 3: Pipeline Analysis (by Company)
Table 4: Pipeline Analysis (by Product)
Table 5: Precision Medicine Drugs Pipeline Analysis
Table 6: Ecosystem Summary
Table 7: Precision Medicine Market (by Region), $Million, 2023-2034
Table 8: Asia-Pacific Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 9: Japan Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 10: China Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 11: India Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 12: Australia Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 13: South Korea. Precision Medicine Market (by Ecosystem), $Billion, 2023-2034
Table 14: Rest-of-APAC Precision Medicine Market (by Ecosystem), $Billion, 2023-2034